TJ313B - Erythromycin's dervatives and pharmaceutical composition on their basis - Google Patents

Erythromycin's dervatives and pharmaceutical composition on their basis

Info

Publication number: TJ313B
Authority: TJ; Tajikistan
Prior art keywords: dervatives; erythromycin; basis; pharmaceutical composition; pharmaceutical
Prior art date: 1994-05-03

Application number

TJ96000417A

Other languages

English (en)

Inventor

Constantin Agouridas

Jean-Fransua Shanto

Deni Alexsis

D Ambrier Solange Gouin

Martret Odile Le

Original Assignee

Hoechest Marion Roussel

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-03

Filing date

1996-11-01

Publication date

2001-08-06

1996-11-01 Application filed by Hoechest Marion Roussel filed Critical Hoechest Marion Roussel

2001-08-06 Publication of TJ313B publication Critical patent/TJ313B/xx

Links

ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 title 2
229960003276 erythromycin Drugs 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Virology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Bioinformatics & Cheminformatics (AREA)
Dermatology (AREA)
Tropical Medicine & Parasitology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Indole Compounds (AREA)
Quinoline Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Pyrrole Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)

TJ96000417A 1994-05-03 1996-11-01 Erythromycin's dervatives and pharmaceutical composition on their basis TJ313B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9405368A FR2719587B1 (fr)	1994-05-03	1994-05-03	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Publications (1)

Publication Number	Publication Date
TJ313B true TJ313B (en)	2001-08-06

Family

ID=9462785

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TJ96000417A TJ313B (en)	1994-05-03	1996-11-01	Erythromycin's dervatives and pharmaceutical composition on their basis

Country Status (42)

Country	Link
US (2)	US5635485A (fr)
EP (1)	EP0680967B1 (fr)
JP (4)	JP2992540B2 (fr)
KR (1)	KR100312267B1 (fr)
CN (2)	CN1052984C (fr)
AP (1)	AP558A (fr)
AT (1)	ATE172203T1 (fr)
AU (1)	AU684027B2 (fr)
BG (1)	BG63087B1 (fr)
BR (1)	BR9507700A (fr)
CA (1)	CA2189271C (fr)
CZ (1)	CZ293455B6 (fr)
DE (2)	DE69505296T2 (fr)
DK (1)	DK0680967T3 (fr)
DZ (1)	DZ1878A1 (fr)
EE (1)	EE03263B1 (fr)
ES (1)	ES2122472T3 (fr)
FI (1)	FI111263B (fr)
FR (1)	FR2719587B1 (fr)
GE (1)	GEP19991538B (fr)
HU (2)	HU219599B (fr)
IL (1)	IL113245A (fr)
LU (1)	LU90872I2 (fr)
LV (1)	LV11739B (fr)
MA (1)	MA23534A1 (fr)
MD (1)	MD1233C2 (fr)
NL (1)	NL300077I1 (fr)
NO (2)	NO308853B1 (fr)
NZ (1)	NZ285416A (fr)
OA (1)	OA10319A (fr)
PL (1)	PL182034B1 (fr)
RO (1)	RO113350B1 (fr)
RU (1)	RU2144036C1 (fr)
SI (1)	SI0680967T1 (fr)
SK (1)	SK281707B6 (fr)
TJ (1)	TJ313B (fr)
TN (1)	TNSN95049A1 (fr)
TW (1)	TW341573B (fr)
UA (1)	UA51618C2 (fr)
WO (1)	WO1995029929A1 (fr)
YU (1)	YU49235B (fr)
ZA (1)	ZA953501B (fr)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0837850B1 (fr) *	1995-06-27	2004-09-01	Takeda Chemical Industries, Ltd.	Derives de 4-acylamino(halogeno)alkyl-quinoline, leur preparation et leur utilisation comme agonistes de la melatonine
FR2742757B1 (fr)	1995-12-22	1998-01-30	Roussel Uclaf	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
ATE296831T1 (de) *	1996-09-04	2005-06-15	Abbott Lab	6-0-substituierte ketoliden mit antibakteriellen wirkung
UA51730C2 (uk) *	1996-09-04	2002-12-16	Ебботт Лабораторіз	6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
FR2757168B1 (fr) *	1996-12-12	1999-06-11	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) *	1997-02-27	1999-04-30	Hoechst Marion Roussel Inc	Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
US5780605A (en) *	1997-09-08	1998-07-14	Abbott Laboratories	6,9-bridged erythromycin derivatives
FR2771008B1 (fr) *	1997-11-17	2000-04-28	Hoechst Marion Roussel Inc	Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
JP4573925B2 (ja) *	1998-07-09	2010-11-04	アベンティス・ファーマ・ソシエテ・アノニム	新規のエリスロマイシン誘導体、その製造方法及びその薬剤としての使用
FR2781484B1 (fr) *	1998-07-21	2001-08-10	Hoechst Marion Roussel Inc	Nouveaux derives de la 6-deoxy erythromycine, leur procede de preparation et leur application comme medicaments
AU5299499A (en)	1998-09-22	2000-04-10	Pfizer Products Inc.	Carbamate and carbazate ketolide antibiotics
FR2785612A1 (fr) *	1998-11-10	2000-05-12	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2786188B1 (fr) *	1998-11-24	2002-10-31	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
TW526202B (en) *	1998-11-27	2003-04-01	Shionogi & Amp Co	Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
EP1137654A1 (fr)	1998-12-10	2001-10-04	Pfizer Products Inc.	Antibiotiques a base de cetolides de carbamate et de carbazate
AP2001002222A0 (en) *	1999-01-27	2001-09-30	Pfizer Prod Inc	Ketolide antibiotics.
FR2789392B1 (fr) *	1999-02-04	2001-10-05	Hoechst Marion Roussel Inc	Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) *	1999-03-19	2000-04-25	Abbott Laboratories	6-O-substituted macrolides having antibacterial activity
US6514944B2 (en)	1999-04-16	2003-02-04	Kosan Biosciences, Inc.	Macrolide antiinfective agents
US6451768B1 (en)	1999-04-16	2002-09-17	Kosan Biosciences, Inc.	Macrolide antiinfective agents
US6939861B2 (en) *	1999-04-16	2005-09-06	Kosan Biosciences, Inc.	Amido macrolides
JP2002542197A (ja)	1999-04-16	2002-12-10	オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド	ケトライド抗菌剤
US6590083B1 (en)	1999-04-16	2003-07-08	Ortho-Mcneil Pharmaceutical, Inc.	Ketolide antibacterials
AU775637B2 (en)	1999-04-16	2004-08-12	Kosan Biosciences, Inc.	Macrolide antiinfective agents
TR200103395T2 (tr) *	1999-05-24	2002-04-22	Pfizer Products Inc.	13-metil eritromisin türevleri.
FR2797875B1 (fr) *	1999-08-26	2001-10-19	Hoechst Marion Roussel Inc	Agglomerats spheriques de telithromycine, leur procede de preparation et leur application dans la preparation de formes pharmaceutiques
US6946446B2 (en)	2000-02-24	2005-09-20	Abbott Laboratories	Anti-infective agents useful against multidrug-resistant strains of bacteria
AU2001282105A1 (en) *	2000-08-22	2002-03-04	Basilea Pharmaceutica Ag	New macrolides with antibacterial activity
FR2821747B1 (fr) *	2001-03-09	2004-07-02	Ethypharm Lab Prod Ethiques	Suspension de telithromycine a gout masque
JP4509553B2 (ja) *	2001-07-03	2010-07-21	ノバルティスバクシンズアンドダイアグノスティックス，インコーポレーテッド	抗菌活性を有するｃ１２修飾エリスロマイシンマクロライドおよびケトライド
US8063021B2 (en) *	2002-01-17	2011-11-22	Kosan Biosciences Incorporated	Ketolide anti-infective compounds
US6995143B2 (en)	2002-02-28	2006-02-07	Basilea Pharmaceutica Ag	Macrolides with antibacterial activity
JP4790263B2 (ja)	2002-07-08	2011-10-12	グラクソグループリミテッド	炎症性の疾患および病態を治療する新規な化合物、組成物および方法
AU2003264917A1 (en)	2002-07-08	2004-01-23	Pliva - Istrazivacki Institut D.O.O.	Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules
US20040013737A1 (en) *	2002-07-19	2004-01-22	Philippe Becourt	Taste masked oral composition of telithromycin
WO2004009059A1 (fr) *	2002-07-19	2004-01-29	Aventis Pharma S.A.	Composition orale de telithromycine possedant un gout agreable
TW200420573A (en)	2002-09-26	2004-10-16	Rib X Pharmaceuticals Inc	Bifunctional heterocyclic compounds and methods of making and using same
DE10305391A1 (de) *	2003-02-11	2004-08-19	Aventis Pharma Deutschland Gmbh	Verfahren zur Herstellung von Pyridin-substituierten Aminoketal-Derivaten
US6916934B2 (en) *	2003-02-11	2005-07-12	Aventis Pharma Deutschland Gmbh	Process for preparing pyridine-substituted amino ketal derivatives
EP3738591A3 (fr) *	2003-03-10	2021-03-24	Merck Sharp & Dohme Corp.	Nouveaux agents antibactériens
US7163924B2 (en) *	2003-04-25	2007-01-16	Chiron Corporation	Ketolide derivatives
EP1670808A1 (fr) *	2003-09-12	2006-06-21	Chiron Corporation	Derives antimicrobiens
GB0402578D0 (en) *	2004-02-05	2004-03-10	Cambridge Theranostics Ltd	Methods of treatment of atherosclerosis
US8202843B2 (en)	2004-02-27	2012-06-19	Rib-X Pharmaceuticals, Inc.	Macrocyclic compounds and methods of making and using the same
ATE373009T1 (de) *	2004-04-28	2007-09-15	Alembic Ltd	Verfahren zur vorbereitung von telithromycin
BRPI0513903A (pt) *	2004-07-28	2008-05-20	Ranbaxy Lab Ltd	derivados de cetolìdeos úteis como agentes antimicrobianos, seus processos de preparação e composições farmacêuticas compreendendo os mesmos
EP1807439A2 (fr) *	2004-10-25	2007-07-18	Ranbaxy Laboratories Limited	Derives de cetolides utiles comme agents antibacteriens
EA011281B1 (ru)	2004-12-21	2009-02-27	Пфайзер Продактс Инк.	Макролиды
WO2006085507A1 (fr) *	2005-02-08	2006-08-17	Murata Manufacturing Co., Ltd.	Thermistor de caractéristique négative de type à montage en surface
FR2882522B1 (fr)	2005-02-25	2007-04-13	Aventis Pharma Sa	Composition pharmaceutique solide comprenant de la telithromycine
WO2006129257A2 (fr) *	2005-05-30	2006-12-07	Ranbaxy Laboratories Limited	Derives de cetolides utilises comme agents antibacteriens
WO2007039914A2 (fr) *	2005-10-06	2007-04-12	Alembic Limited	Nouveaux polymorphes de compose d'erythromycine
WO2007049296A2 (fr) *	2005-10-28	2007-05-03	Alembic Limited	Nouvelle forme de telithromycine
WO2007059307A2 (fr) *	2005-11-15	2007-05-24	Teva Pharmaceutical Industries Ltd.	Formes amorphes et cristallines de telithromycine
WO2007060518A2 (fr) *	2005-11-23	2007-05-31	Ranbaxy Laboratories Limited	Dérivés de cétolide en tant qu'agents antibactériens
US20090075916A1 (en) *	2005-11-23	2009-03-19	Upadhyay Dilip J	Use of Macrolide Derivatives for Treating Acne
WO2007060618A2 (fr) *	2005-11-23	2007-05-31	Ranbaxy Laboratories Limited	Dérivés macrolides en tant qu’agents antibactériens
US7595300B2 (en)	2005-12-13	2009-09-29	Kosan Biosciences Incorporated	7-quinolyl ketolide antibacterial agents
GB0600238D0 (en) *	2006-01-06	2006-02-15	Sandoz Ag	Organic compounds
EP1985620A4 (fr) *	2006-02-07	2012-08-15	Taisho Pharmaceutical Co Ltd	COMPOSÉ 10a-AZALIDE
KR20090042971A (ko)	2006-08-24	2009-05-04	욱크하르트 리서치 센터	항미생물 활성을 갖는 신규한 마크로라이드 및 케토라이드
WO2008023383A1 (fr) *	2006-08-25	2008-02-28	Alembic Limited	Nouveau procédé de synthèse de la télithromycine
ES2306590B1 (es) *	2006-12-15	2009-08-07	Ercros Industrial,S .A.	Formas cristalinas i y ii de telitromicina.
US8293715B2 (en) *	2007-08-06	2012-10-23	Taisho Pharmaceutical Co., Ltd.	10a-Azalide compound crosslinked at 10a- and 12-positions
US20090075917A1 (en) *	2007-09-19	2009-03-19	Protia, Llc	Deuterium-enriched telithromycin
EP2798977B1 (fr)	2007-09-20	2017-11-08	Herman Miller, Inc.	Structure de support de charge
CN101917850B (zh)	2007-10-25	2016-01-13	森普拉制药公司	大环内酯类抗菌剂的制备方法
EP2220104A1 (fr) *	2007-10-25	2010-08-25	Sandoz AG	Procédé de fabrication de télithromycine
JPWO2009139181A1 (ja)	2008-05-15	2011-09-15	大正製薬株式会社	４員環構造を有する１０ａ−アザライド化合物
DK2358379T3 (en) *	2008-10-24	2016-03-07	Cempra Pharmaceuticals Inc	BIOFORSVAR USING TRIAZOLHOLDIGE macrolides
EP2435460B1 (fr)	2009-05-27	2015-01-07	Wockhardt Limited	Composés kétolides à activité antimicrobienne
US9937194B1 (en)	2009-06-12	2018-04-10	Cempra Pharmaceuticals, Inc.	Compounds and methods for treating inflammatory diseases
EP2475253B1 (fr)	2009-09-10	2016-10-26	Cempra Pharmaceuticals, Inc.	Méthodes de traitement du paludisme, de la tuberculose et des maladies à complexe mycobacterium avium (mac)
BR112012023950A2 (pt)	2010-03-22	2016-07-05	Cempra Pharmaceuticals Inc	formas cristalinas de um macrolídeo, e usos dos mesmos
PL2571506T3 (pl)	2010-05-20	2017-10-31	Cempra Pharmaceuticals Inc	Sposoby sporządzania makrolidów i ketolidów oraz ich produktów pośrednich
US9815863B2 (en)	2010-09-10	2017-11-14	Cempra Pharmaceuticals, Inc.	Hydrogen bond forming fluoro ketolides for treating diseases
CN105669803A (zh)	2010-12-09	2016-06-15	沃克哈特有限公司	酮内酯化合物
AR085286A1 (es)	2011-02-21	2013-09-18	Taisho Pharmaceutical Co Ltd	Derivado de macrolido sustituido en la posicion c-4
KR101567658B1 (ko)	2011-03-01	2015-11-09	욱크하르트 리미티드	케톨리드 중간체의 제조 방법
ES2603227T3 (es)	2011-03-22	2017-02-24	Wockhardt Limited	Proceso para la preparación de compuestos cetólidos
MX2014011537A (es)	2012-03-27	2015-02-10	Cempra Pharmaceuticals Inc	Formulaciones parenterales para la administracion de antibioticos macrolidos.
WO2014152326A1 (fr)	2013-03-14	2014-09-25	Cempra Pharmaceuticals, Inc.	Procédés pour traiter des maladies respiratoires et formulations pour la mise en œuvre de ceux-ci
BR112015023670A2 (pt)	2013-03-15	2017-07-18	Cempra Pharmaceuticals Inc	processo para preparar um composto
CN105524132B (zh) *	2014-09-30	2019-07-02	中国医学科学院药物研究所	含有喹啉取代基的红霉素a酮内酯类抗生素衍生物、其制备方法及应用
DE102015201783A1 (de)	2015-02-02	2016-08-04	Friedrich Baur	Verfahren zur Herstellung eines Füllstoffs aus Textilfasern sowie Textil mit einem solchen Füllstoff
CN107129514B (zh) *	2016-03-02	2019-12-13	中国医学科学院药物研究所	红霉素a酮内酯类抗生素衍生物、其制备方法及应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AT342770B (de) *	1975-04-07	1978-04-25	Thomae Gmbh Dr K	Verfahren zur herstellung neuer erythromycinderivate
DE2833140A1 (de) *	1978-07-28	1980-02-07	Boehringer Sohn Ingelheim	Neue n-substituierte heterocyclen
US4434174A (en) *	1980-02-11	1984-02-28	Berlex Laboratories, Inc.	Treating cardiovascular diseases with N-(3-phenoxy-2-hydroxypropyl)benzimidazole-1-alkanamines
IE810250L (en) *	1980-02-11	1981-08-11	Berlex Lab	N-(3-phenoxy-2-hydroxypropyl) benzimidazole -1-¹alkanamines.
US4568687A (en) *	1983-02-28	1986-02-04	American Cyanamid Company	N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical compositions
ZA84949B (en) *	1983-04-06	1984-09-26	American Cyanamid Co	Substituted-n-(2-4-(1h-imidazol-1-yl)alkyl)substituted amides
US4489089A (en) *	1983-04-06	1984-12-18	American Cyanamid Company	Substituted N-[ω-(1H-imidazol-1-yl)alkyl]-amides
AU573828B2 (en) *	1984-05-17	1988-06-23	E.R. Squibb & Sons, Inc.	Tetrahydronaphthalenols
GB8425104D0 (en) *	1984-10-04	1984-11-07	Ici America Inc	Amide derivatives
DE3540376A1 (de) *	1985-11-14	1987-05-21	Bayer Ag	Verfahren zur inhibierung der wasserstoffinduzierten korrosion von metallischen werkstoffen
EP0269239B1 (fr) *	1986-10-29	1994-06-08	Pfizer Inc.	Procédés de préparation de (pentyl-1-guanidino-3)-2-(méthyl-2-imidazolyl-4)-4-thiazole et son dihydrochloride trihydrate cristallin
DE3930669A1 (de) *	1989-09-14	1991-03-28	Basf Ag	Verfahren zur herstellung von uretdiongruppen aufweisenden polyisocyanaten
JP2899028B2 (ja) *	1989-12-01	1999-06-02	協和醗酵工業株式会社	ジベンゾオキセピン誘導体
IL99995A (en) *	1990-11-21	1997-11-20	Roussel Uclaf	Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
ES2104889T3 (es) *	1990-11-28	1997-10-16	Taisho Pharmaceutical Co Ltd	Derivado de 6-o-metileritromicina a.
FR2692579B1 (fr) *	1992-06-19	1995-06-02	Roussel Uclaf	Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) *	1992-11-05	1996-06-18	Roussel Uclaf	Erythromycin derivatives
FR2697524B1 (fr) *	1992-11-05	1994-12-23	Roussel Uclaf	Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
TW444018B (en) *	1992-12-17	2001-07-01	Pfizer	Pyrazolopyrimidines
HRP930014A2 (en) *	1993-01-08	1994-08-31	Pliva Pharm & Chem Works	9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates

1994
- 1994-05-03 FR FR9405368A patent/FR2719587B1/fr not_active Expired - Lifetime
1995
- 1995-02-05 UA UA96104110A patent/UA51618C2/uk unknown
- 1995-04-04 IL IL11324595A patent/IL113245A/xx not_active IP Right Cessation
- 1995-04-21 US US08/426,067 patent/US5635485A/en not_active Expired - Lifetime
- 1995-04-27 MA MA23866A patent/MA23534A1/fr unknown
- 1995-04-28 YU YU27095A patent/YU49235B/sh unknown
- 1995-05-01 JP JP7128791A patent/JP2992540B2/ja not_active Expired - Lifetime
- 1995-05-02 DE DE69505296T patent/DE69505296T2/de not_active Expired - Lifetime
- 1995-05-02 EP EP95400987A patent/EP0680967B1/fr not_active Expired - Lifetime
- 1995-05-02 GE GEAP19953425A patent/GEP19991538B/en unknown
- 1995-05-02 DK DK95400987T patent/DK0680967T3/da active
- 1995-05-02 ZA ZA953501A patent/ZA953501B/xx unknown
- 1995-05-02 ES ES95400987T patent/ES2122472T3/es not_active Expired - Lifetime
- 1995-05-02 HU HU9904687A patent/HU219599B/hu unknown
- 1995-05-02 CZ CZ19963214A patent/CZ293455B6/cs not_active IP Right Cessation
- 1995-05-02 DZ DZ950049A patent/DZ1878A1/fr active
- 1995-05-02 BR BR9507700A patent/BR9507700A/pt not_active IP Right Cessation
- 1995-05-02 RU RU96123129A patent/RU2144036C1/ru active
- 1995-05-02 AU AU24499/95A patent/AU684027B2/en not_active Expired
- 1995-05-02 MD MD97-0010A patent/MD1233C2/ro unknown
- 1995-05-02 DE DE2002199001 patent/DE10299001I2/de active Active
- 1995-05-02 AP APAP/P/1995/000744A patent/AP558A/en active
- 1995-05-02 AT AT95400987T patent/ATE172203T1/de active
- 1995-05-02 CN CN95193911A patent/CN1052984C/zh not_active Expired - Lifetime
- 1995-05-02 CA CA002189271A patent/CA2189271C/fr not_active Expired - Lifetime
- 1995-05-02 PL PL95317071A patent/PL182034B1/pl unknown
- 1995-05-02 HU HU9603038A patent/HU227493B1/hu unknown
- 1995-05-02 WO PCT/FR1995/000565 patent/WO1995029929A1/fr not_active Ceased
- 1995-05-02 SI SI9530184T patent/SI0680967T1/xx unknown
- 1995-05-02 SK SK1402-96A patent/SK281707B6/sk not_active IP Right Cessation
- 1995-05-02 RO RO96-02081A patent/RO113350B1/ro unknown
- 1995-05-02 NZ NZ285416A patent/NZ285416A/en not_active IP Right Cessation
- 1995-05-02 TN TNTNSN95049A patent/TNSN95049A1/fr unknown
- 1995-05-02 EE EE9600151A patent/EE03263B1/xx active Protection Beyond IP Right Term
- 1995-05-02 KR KR1019960706191A patent/KR100312267B1/ko not_active Expired - Lifetime
- 1995-06-29 TW TW084106692A patent/TW341573B/zh not_active IP Right Cessation
1996
- 1996-10-31 FI FI964395A patent/FI111263B/fi not_active IP Right Cessation
- 1996-11-01 OA OA60917A patent/OA10319A/fr unknown
- 1996-11-01 BG BG100951A patent/BG63087B1/bg unknown
- 1996-11-01 TJ TJ96000417A patent/TJ313B/xx unknown
- 1996-11-01 LV LVP-96-421A patent/LV11739B/lv unknown
- 1996-11-04 NO NO964654A patent/NO308853B1/no not_active IP Right Cessation
1997
- 1997-01-09 US US08/780,861 patent/US6100404A/en not_active Expired - Lifetime
1998
- 1998-08-24 JP JP25181798A patent/JP3998828B2/ja not_active Expired - Lifetime
- 1998-12-07 CN CN98123072A patent/CN1088709C/zh not_active Expired - Lifetime
2001
- 2001-12-28 NL NL300077C patent/NL300077I1/nl unknown
- 2001-12-28 NO NO2001027C patent/NO2001027I1/no unknown
2002
- 2002-01-08 LU LU90872C patent/LU90872I2/fr unknown
2006
- 2006-11-21 JP JP2006314281A patent/JP4658902B2/ja not_active Expired - Lifetime
2007
- 2007-06-06 JP JP2007150991A patent/JP4750755B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
UA51618C2 (uk)	2002-12-16
HU227493B1 (en)	2011-07-28
HU9603038D0 (en)	1997-01-28
LV11739B (en)	1997-08-20
FI964395L (fi)	1996-10-31
CN1151746A (zh)	1997-06-11
CN1052984C (zh)	2000-05-31
JPH11152296A (ja)	1999-06-08
ES2122472T3 (es)	1998-12-16
CZ321496A3 (en)	1997-08-13
SI0680967T1 (en)	1999-02-28
CA2189271C (fr)	2005-12-27
JPH0853489A (ja)	1996-02-27
FR2719587B1 (fr)	1996-07-12
CA2189271A1 (fr)	1995-11-09
JP4750755B2 (ja)	2011-08-17
TNSN95049A1 (fr)	1996-02-06
DZ1878A1 (fr)	2002-02-17
FI111263B (fi)	2003-06-30
SK281707B6 (sk)	2001-07-10
ATE172203T1 (de)	1998-10-15
YU49235B (sh)	2004-12-31
MD1233B1 (en)	1999-05-31
JP3998828B2 (ja)	2007-10-31
BG100951A (en)	1997-08-29
AU2449995A (en)	1995-11-29
DE69505296T2 (de)	1999-04-22
JP2007269810A (ja)	2007-10-18
NO2001027I1 (no)	2002-01-28
LU90872I2 (fr)	2002-03-12
US6100404A (en)	2000-08-08
DE69505296D1 (de)	1998-11-19
NO964654L (no)	1996-11-04
YU27095A (sh)	1998-05-15
PL182034B1 (pl)	2001-10-31
BR9507700A (pt)	1997-08-19
MA23534A1 (fr)	1995-12-31
GEP19991538B (en)	1999-03-05
NZ285416A (en)	1997-07-27
KR100312267B1 (ko)	2002-06-22
CN1088709C (zh)	2002-08-07
DE10299001I1 (de)	2012-07-05
DE10299001I2 (de)	2012-07-05
DK0680967T3 (da)	1999-06-23
CN1229082A (zh)	1999-09-22
AP9500744A0 (en)	1995-07-31
JP4658902B2 (ja)	2011-03-23
RO113350B1 (ro)	1998-06-30
BG63087B1 (bg)	2001-03-30
AP558A (en)	1996-11-07
OA10319A (fr)	1997-10-07
JP2007045847A (ja)	2007-02-22
HK1010732A1 (en)	1999-06-25
AU684027B2 (en)	1997-11-27
WO1995029929A1 (fr)	1995-11-09
MD1233C2 (ro)	2000-10-31
CZ293455B6 (cs)	2004-05-12
MX9605208A (es)	1997-09-30
IL113245A0 (en)	1995-07-31
JP2992540B2 (ja)	1999-12-20
US5635485A (en)	1997-06-03
IL113245A (en)	1999-11-30
FI964395A0 (fi)	1996-10-31
FR2719587A1 (fr)	1995-11-10
EE03263B1 (et)	2000-04-17
HU9904687D0 (en)	2000-03-28
ZA953501B (en)	1996-05-02
EP0680967B1 (fr)	1998-10-14
HUT75698A (en)	1997-05-28
PL317071A1 (en)	1997-03-03
LV11739A (lv)	1997-04-20
NO308853B1 (no)	2000-11-06
NL300077I1 (nl)	2002-03-01
EP0680967A1 (fr)	1995-11-08
RU2144036C1 (ru)	2000-01-10
SK140296A3 (en)	1998-04-08
NO964654D0 (no)	1996-11-04
HU219599B (hu)	2001-05-28
TW341573B (en)	1998-10-01

Publication	Publication Date	Title
TJ313B (en)	2001-08-06	Erythromycin's dervatives and pharmaceutical composition on their basis
IL117859A0 (en)	1996-08-04	Isothiazolones and their uses
IL122428A0 (en)	1998-06-15	Minizymes and minribozymes and uses thereof
HU0500976D0 (en)	2005-12-28	Pharmaceutical formulations containing darifenacin
IL122216A0 (en)	1998-04-05	Dolastatin derivatives their preparation and use
HUP9801819A3 (en)	1998-12-28	Synergetic phytomicrobicide compositions and use thereof
GB9525812D0 (en)	1996-02-21	Composition and use
IL118442A0 (en)	1996-09-12	Triazolymethyl-cyclopentanols their preparation and use
EP0803255A4 (fr)	1999-06-30	Composition medicinale
IL118441A0 (en)	1996-09-12	Triazolymethyl-oxiranes their preparation and use
IL135723A (en)	2005-11-20	1'-Ä4-Ä1-4-Fluorophenyl)-1H-indole-3-ylÜ-1-butylÜ-spiroÄisobenzofuran-1-(3H),4'-piperidineÜhydrohal ogenides and pharmaceutical compositions containing them
HUP0000460A3 (en)	2001-04-28	Imidazopyridazines and pharmaceutical compositions thereof
GB9518692D0 (en)	1995-11-15	'Spraymate'
GB9501286D0 (en)	1995-03-15	Pharmaceutical compositions and preparations thereof
IL124415A (en)	2003-11-23	N, n'-bridged bisindolylmaleimides, their preparation and pharmaceutical compositions containing them
IL122686A0 (en)	1998-08-16	Benzylhydroxylamines their preparation and use
IL118444A0 (en)	1996-09-12	Mercapto-triazolyl-silanes their preparation and use
IL117045A0 (en)	1996-06-18	Substituted 2,3-dihydro-1,4-dioxinopyridines their preparation and pharmaceutical compositions containing them
IL114161A0 (en)	1995-10-31	Amido- quinoxalinediones pharmaceutical compositions containing them and their use
GB9515285D0 (en)	1995-09-20	"Absorbent materials"
GB9503462D0 (en)	1995-04-12	"Cleaning composition and its use"
GB9512703D0 (en)	1995-08-23	Composition and use
GB9519849D0 (en)	1995-11-29	Pharmaceutical compositions and their use
GB9503463D0 (en)	1995-04-12	"Cleaning composition and method"
HUP9602732A2 (en)	1997-09-29	Pharmaceutical composition comprising lanperisone